Clinical Trial Update: BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for BP-C1 in metastatic/unresectable pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• BP-C1

Snippet

Sponsor: Meabco A/S | Conditions: Metastatic Pancreatic Cancer, Unresectable Pancreatic Cancer | Phase 2 | Status: COMPLETED